Shopping Cart 0
Cart Subtotal
AED 0

Global Pulmonary Hypertension Drugs Market Analysis 2013-2018 and Forecast 2019-2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 10937

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
AED 11671

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 21873

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 21873

Details

Snapshot

The global Pulmonary Hypertension Drugs market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Pulmonary Hypertension Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Prostacyclin and prostacyclin analogs

Endothelin receptor antagonists (ERAs)

Phosphodiesterase-5 (PDE-5) inhibitors

Soluble guanylate cyclase (sGC) stimulators

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Bayer

GSK

Arena

Actelion

Pfizer

United Therapeutics

Gilead Sciences

Lung Biotechnology PBC

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Early-stage Drug Candidates (Phase I & Phase II)

Late-stage Drug Candidates (Phase III & Registration Phase)

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Table Of Content

Scope

Table of Contents

1 Industry Overview

1.1 Pulmonary Hypertension Drugs Industry

1.1.1 Overview

1.1.2 Development of Pulmonary Hypertension Drugs

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Pulmonary Hypertension Drugs Market by Type

3.1 By Type

3.1.1 Prostacyclin and prostacyclin analogs

3.1.2 Endothelin receptor antagonists (ERAs)

3.1.3 Phosphodiesterase-5 (PDE-5) inhibitors

3.1.4 Soluble guanylate cyclase (sGC) stimulators

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Pulmonary Hypertension Drugs Bayer (Company Profile, Sales Data etc.)

4.2 GSK (Company Profile, Sales Data etc.)

4.3 Arena (Company Profile, Sales Data etc.)

4.4 Actelion (Company Profile, Sales Data etc.)

4.5 Pfizer (Company Profile, Sales Data etc.)

4.6 United Therapeutics (Company Profile, Sales Data etc.)

4.7 Gilead Sciences (Company Profile, Sales Data etc.)

4.8 Lung Biotechnology PBC (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Early-stage Drug Candidates (Phase I & Phase II)

6.1.2 Demand in Late-stage Drug Candidates (Phase III & Registration Phase)

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Pulmonary Hypertension Drugs Market Growth 2013-2018, by Type, in USD Million

Figure Global Pulmonary Hypertension Drugs Market Growth 2013-2018, by Type, in Volume

Figure North America Pulmonary Hypertension Drugs Market Concentration, in 2018

Figure Europe Pulmonary Hypertension Drugs Market Market Concentration, in 2018

Figure Asia-Pacific Pulmonary Hypertension Drugs MMarket Concentration, in 2018

Figure South America Pulmonary Hypertension Drugs Market Concentration, in 2018

Figure Middle East & Africa Pulmonary Hypertension Drugs Market Concentration, in 2018

Figure Pulmonary Hypertension Drugs Demand in Early-stage Drug Candidates (Phase I & Phase II), 2013-2018, in USD Million

Figure Pulmonary Hypertension Drugs Demand in Early-stage Drug Candidates (Phase I & Phase II), 2013-2018, in Volume

Figure Pulmonary Hypertension Drugs Demand in Late-stage Drug Candidates (Phase III & Registration Phase), 2013-2018, in USD Million

Figure Pulmonary Hypertension Drugs Demand in Late-stage Drug Candidates (Phase III & Registration Phase), 2013-2018, in Volume

Figure North America Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in USD Million

Figure North America Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in Volume

Figure Europe Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in USD Million

Figure Europe Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in Volume

Figure South America Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in USD Million

Figure South America Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Pulmonary Hypertension Drugs

Table Application Segment of Pulmonary Hypertension Drugs

Table Global Pulmonary Hypertension Drugs Market 2013-2024, by Application, in USD Million

Table Major Company List of Prostacyclin and prostacyclin analogs

Table Major Company List of Endothelin receptor antagonists (ERAs)

Table Major Company List of Phosphodiesterase-5 (PDE-5) inhibitors

Table Major Company List of Soluble guanylate cyclase (sGC) stimulators

Table Global Pulmonary Hypertension Drugs Market 2013-2018, by Type, in USD Million

Table Global Pulmonary Hypertension Drugs Market 2013-2018, by Type, in Volume

Table Global Pulmonary Hypertension Drugs Market Forecast 2019-2024, by Type, in USD Million

Table Global Pulmonary Hypertension Drugs Market Forecast 2019-2024, by Type, in Volume

Table Bayer Overview List

Table Pulmonary Hypertension Drugs Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GSK Overview List

Table Pulmonary Hypertension Drugs Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Arena Overview List

Table Pulmonary Hypertension Drugs Business Operation of Arena (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Actelion Overview List

Table Pulmonary Hypertension Drugs Business Operation of Actelion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Pulmonary Hypertension Drugs Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table United Therapeutics Overview List

Table Pulmonary Hypertension Drugs Business Operation of United Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Gilead Sciences Overview List

Table Pulmonary Hypertension Drugs Business Operation of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Lung Biotechnology PBC Overview List

Table Pulmonary Hypertension Drugs Business Operation of Lung Biotechnology PBC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Pulmonary Hypertension Drugs Sales Revenue 2013-2018, by Company, in USD Million

Table Global Pulmonary Hypertension Drugs Sales Revenue Share, by Company, in USD Million

Table Global Pulmonary Hypertension Drugs Sales Volume 2013-2018, by Company, in Volume

Table Global Pulmonary Hypertension Drugs Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Pulmonary Hypertension Drugs Demand Forecast 2019-2024, by Application, in USD Million

Table Pulmonary Hypertension Drugs Demand Forecast 2019-2024, by Application, in Volume

Table Pulmonary Hypertension Drugs Production 2013-2018, by Region, in USD Million

Table Pulmonary Hypertension Drugs Production 2013-2018, by Region, in Volume

Table Global Pulmonary Hypertension Drugs Market 2013-2018, by Region, in USD Million

Table Global Pulmonary Hypertension Drugs Market Share 2013-2018, by Region, in USD Million

Table Global Pulmonary Hypertension Drugs Market 2013-2018, by Region, in Volume

Table Global Pulmonary Hypertension Drugs Market Share 2013-2018, by Region, in Volume

Table North America Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in USD Million

Table North America Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in Volume

Table Europe Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in USD Million

Table Europe Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in Volume

Table South America Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in USD Million

Table South America Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in Volume

Table Pulmonary Hypertension Drugs Market Forecast 2019-2024, by Region, in USD Million

Table Pulmonary Hypertension Drugs Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

Licence Rights

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Snapshot

The global Pulmonary Hypertension Drugs market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Pulmonary Hypertension Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Prostacyclin and prostacyclin analogs

Endothelin receptor antagonists (ERAs)

Phosphodiesterase-5 (PDE-5) inhibitors

Soluble guanylate cyclase (sGC) stimulators

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Bayer

GSK

Arena

Actelion

Pfizer

United Therapeutics

Gilead Sciences

Lung Biotechnology PBC

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Early-stage Drug Candidates (Phase I & Phase II)

Late-stage Drug Candidates (Phase III & Registration Phase)

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Scope

Table of Contents

1 Industry Overview

1.1 Pulmonary Hypertension Drugs Industry

1.1.1 Overview

1.1.2 Development of Pulmonary Hypertension Drugs

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Pulmonary Hypertension Drugs Market by Type

3.1 By Type

3.1.1 Prostacyclin and prostacyclin analogs

3.1.2 Endothelin receptor antagonists (ERAs)

3.1.3 Phosphodiesterase-5 (PDE-5) inhibitors

3.1.4 Soluble guanylate cyclase (sGC) stimulators

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Pulmonary Hypertension Drugs Bayer (Company Profile, Sales Data etc.)

4.2 GSK (Company Profile, Sales Data etc.)

4.3 Arena (Company Profile, Sales Data etc.)

4.4 Actelion (Company Profile, Sales Data etc.)

4.5 Pfizer (Company Profile, Sales Data etc.)

4.6 United Therapeutics (Company Profile, Sales Data etc.)

4.7 Gilead Sciences (Company Profile, Sales Data etc.)

4.8 Lung Biotechnology PBC (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Early-stage Drug Candidates (Phase I & Phase II)

6.1.2 Demand in Late-stage Drug Candidates (Phase III & Registration Phase)

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Pulmonary Hypertension Drugs Market Growth 2013-2018, by Type, in USD Million

Figure Global Pulmonary Hypertension Drugs Market Growth 2013-2018, by Type, in Volume

Figure North America Pulmonary Hypertension Drugs Market Concentration, in 2018

Figure Europe Pulmonary Hypertension Drugs Market Market Concentration, in 2018

Figure Asia-Pacific Pulmonary Hypertension Drugs MMarket Concentration, in 2018

Figure South America Pulmonary Hypertension Drugs Market Concentration, in 2018

Figure Middle East & Africa Pulmonary Hypertension Drugs Market Concentration, in 2018

Figure Pulmonary Hypertension Drugs Demand in Early-stage Drug Candidates (Phase I & Phase II), 2013-2018, in USD Million

Figure Pulmonary Hypertension Drugs Demand in Early-stage Drug Candidates (Phase I & Phase II), 2013-2018, in Volume

Figure Pulmonary Hypertension Drugs Demand in Late-stage Drug Candidates (Phase III & Registration Phase), 2013-2018, in USD Million

Figure Pulmonary Hypertension Drugs Demand in Late-stage Drug Candidates (Phase III & Registration Phase), 2013-2018, in Volume

Figure North America Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in USD Million

Figure North America Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in Volume

Figure Europe Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in USD Million

Figure Europe Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in Volume

Figure South America Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in USD Million

Figure South America Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Pulmonary Hypertension Drugs Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Pulmonary Hypertension Drugs

Table Application Segment of Pulmonary Hypertension Drugs

Table Global Pulmonary Hypertension Drugs Market 2013-2024, by Application, in USD Million

Table Major Company List of Prostacyclin and prostacyclin analogs

Table Major Company List of Endothelin receptor antagonists (ERAs)

Table Major Company List of Phosphodiesterase-5 (PDE-5) inhibitors

Table Major Company List of Soluble guanylate cyclase (sGC) stimulators

Table Global Pulmonary Hypertension Drugs Market 2013-2018, by Type, in USD Million

Table Global Pulmonary Hypertension Drugs Market 2013-2018, by Type, in Volume

Table Global Pulmonary Hypertension Drugs Market Forecast 2019-2024, by Type, in USD Million

Table Global Pulmonary Hypertension Drugs Market Forecast 2019-2024, by Type, in Volume

Table Bayer Overview List

Table Pulmonary Hypertension Drugs Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GSK Overview List

Table Pulmonary Hypertension Drugs Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Arena Overview List

Table Pulmonary Hypertension Drugs Business Operation of Arena (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Actelion Overview List

Table Pulmonary Hypertension Drugs Business Operation of Actelion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Pulmonary Hypertension Drugs Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table United Therapeutics Overview List

Table Pulmonary Hypertension Drugs Business Operation of United Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Gilead Sciences Overview List

Table Pulmonary Hypertension Drugs Business Operation of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Lung Biotechnology PBC Overview List

Table Pulmonary Hypertension Drugs Business Operation of Lung Biotechnology PBC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Pulmonary Hypertension Drugs Sales Revenue 2013-2018, by Company, in USD Million

Table Global Pulmonary Hypertension Drugs Sales Revenue Share, by Company, in USD Million

Table Global Pulmonary Hypertension Drugs Sales Volume 2013-2018, by Company, in Volume

Table Global Pulmonary Hypertension Drugs Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Pulmonary Hypertension Drugs Demand Forecast 2019-2024, by Application, in USD Million

Table Pulmonary Hypertension Drugs Demand Forecast 2019-2024, by Application, in Volume

Table Pulmonary Hypertension Drugs Production 2013-2018, by Region, in USD Million

Table Pulmonary Hypertension Drugs Production 2013-2018, by Region, in Volume

Table Global Pulmonary Hypertension Drugs Market 2013-2018, by Region, in USD Million

Table Global Pulmonary Hypertension Drugs Market Share 2013-2018, by Region, in USD Million

Table Global Pulmonary Hypertension Drugs Market 2013-2018, by Region, in Volume

Table Global Pulmonary Hypertension Drugs Market Share 2013-2018, by Region, in Volume

Table North America Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in USD Million

Table North America Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in Volume

Table Europe Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in USD Million

Table Europe Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in Volume

Table South America Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in USD Million

Table South America Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Pulmonary Hypertension Drugs Market Size 2013-2018, by Country, in Volume

Table Pulmonary Hypertension Drugs Market Forecast 2019-2024, by Region, in USD Million

Table Pulmonary Hypertension Drugs Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS